Hypoxia-selective antitumor agents derived from 1,9-diazaanthracene
摘要:
The nitroacridine derivative 9-[3-(N,N-dimethylamino)propylamino]-1-nitroacridine (nitracrine) is a potent hypoxia-selective cytotoxin for tumor cells in culture. Modifications of the acridine ring result in altered DNA binding properties. This has suggested the possibility of preparing new nitracrine analogues retaining the nitro group and the alkylamino lateral chain. In this paper we describe the synthesis of the new diazaanthracenes 4, 5, 6 in order to study the relationships between the heterocyclic system and the hypoxia-selective cytotoxicity. This class of new bioreductive agents may constitute a group of potential interest for the design of new cytotoxins.
Hypoxia-selective antitumor agents derived from 1,9-diazaanthracene
摘要:
The nitroacridine derivative 9-[3-(N,N-dimethylamino)propylamino]-1-nitroacridine (nitracrine) is a potent hypoxia-selective cytotoxin for tumor cells in culture. Modifications of the acridine ring result in altered DNA binding properties. This has suggested the possibility of preparing new nitracrine analogues retaining the nitro group and the alkylamino lateral chain. In this paper we describe the synthesis of the new diazaanthracenes 4, 5, 6 in order to study the relationships between the heterocyclic system and the hypoxia-selective cytotoxicity. This class of new bioreductive agents may constitute a group of potential interest for the design of new cytotoxins.